Correlation Between KRAS Mutation Status and Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer☆

Lung Cancer - Netherlands
doi 10.1016/j.lungcan.2015.11.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

KRAS Mutation, KRAS–LCS6 Polymorphism, and Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2010English

Circulating Nucleosomes Predict the Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

P3.01-61 EGFR and KRAS Mutational Status and Significance in Greek Patients With Advanced Non Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2013English

Clinical Response to Chemotherapy in Non-Small Cell Lung Carcinoma Patients

International Journal of Research in Medical Sciences
2019English

Association Between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated With Chemotherapy

PLoS ONE
Multidisciplinary
2012English

EGFR Mutation Status in Tunisian Non-Small-Cell Lung Cancer Patients Evaluated by Mutation-Specific Immunohistochemistry

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2018English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy